LIVE Symposium
Tuesday, May 20, 2025
11:00 AM - 3:30 PM ET
From simple physiological measurements and small molecules to imaging and histologic information, biomarkers found within the human body reveal valuable insights into health and disease. These key indicators can facilitate early disease detection, monitor progression, guide diagnostic and therapeutic decisions, and expand scientists' understanding of complex biological processes.
In this symposium brought to you by The Scientist, researchers will discuss how they discovered novel biomarkers for hepatocellular carcinoma (HCC), amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD), malignant glioma, and systemic sclerosis.
Symposium program
11:00 AM – Opening Remarks
11:10 AM- p62 and NBR1: Balancing Tumor Promotion and Immune Activation in HCC
Jorge Moscat, PhD
11:50 AM – TBD
Platinum Sponsor
12:35 PM – A Novel Fluid Biomarker Reveals TDP-43 Dysfunction in Presymptomatic ALS-FTD
Katie Irwin, PhD
1:15 PM - The Evolution of AD Diagnosis: The Role of Biomarkers
Francesca I. De Simone, PhD
1:40 PM - Molecular and Functional Precision Medicine in the Treatment of Malignant Glioma
David Nathanson, PhD
2:20 PM- 3D High-Multiplex Imaging in Cancer Immunology
Luis Alvarez
2:45 PM- Scleroderma: Sex Differences in Immune Sugars Point to Potential New Diagnostics
Lisa Willis, PhD
3:25 PM- Closing Remarks
![]() | Jorge Moscat, PhD |
![]() | Katie Irwin |
![]() | David Nathanson, PhD |
![]() | Lisa Willis, PhD |
![]() | Francesca I. De Simone, PhD |
![]() | Luis Alvarez Application Manager, Functional Imaging Leica Microsystems CMS GmbH |
Gold Sponsor

Silver Sponsors